AUA 2008: Access to urologists and prostate cancer screenings lead to better outcomes for patients

May 15, 2008

ORLANDO, FL, May 21, 2008--Men with greater access to prostate cancer screenings and treatment have better outcomes from the disease, a new study shows. Urologist population density was directly related to increased numbers of screening programs and decreased mortality rates from the disease. Today, researchers from the University of Alabama, Birmingham, presented data from the Behavioral Risk Factor Surveillance System of the Centers for Disease Control and Prevention (CDC) confirming the relationship. The data was presented to the media during a special press conference on May 21, 2008 at 11:30 a.m.

It has been established that prostate cancer screening programs result in earlier detection of the disease and, as a result, greater treatment options and better outcomes for the majority of patients. Findings suggest that prostate cancer screening and the availability of urologic care are at least partly responsible for the variation in prostate cancer mortality rates observed in this country. Researchers say that this study underscores an increased need for screening programs and access to urologists for patients who reside in areas with fewer urologists.

In the study, researchers compared mortality rates for white males with state-specific screening rates and urologist population densities. Multivariate linear regression analysis was performed, with controls for medical care access, socioeconomic status, median family income, degree of urbanization and insurance status. Both urologist population density and PSA screening rates correlated with mortality rates, and multi-variable linear regression analysis demonstrated them to be significant independent predictors of mortality.
-end-
NOTE TO REPORTERS: Experts are available to discuss these studies outside normal briefing times. To arrange an interview with an expert, please contact the AUA Communications Office at the number above or e-mail Wendy Isett at wisett@auanet.org.

Colli JL, Stands C, Martin B, Amling CL: Urologist population density and PSA screening practices predict prostate cancer mortality rates in the United States. J Urol, suppl., 2008; 179: 687, abstract 2000.

About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is the pre-eminent professional organization for urologists, with more than 15,000 members throughout the world. An educational nonprofit organization, the AUA pursues its mission of fostering the highest standards of urologic care by carrying out a wide variety of programs members and their patients, including UrologyHealth.org, an award-winning on-line patient education resource, and the American Urological Association Foundation, Inc.

American Urological Association

Related Mortality Articles from Brightsurf:

Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
A research by the Universitat Rovira i Virgili (URV) and Pere Virgili Institut (IISPV) led by LluĂ­s Masana has found that people who are being treated with statins have a 22% to 25% lower risk of dying from COVID-19.

Mortality rate higher for US rural residents
A recent study by Syracuse University sociology professor Shannon Monnat shows that mortality rates are higher for U.S. working-age residents who live in rural areas instead of metro areas, and the gap is getting wider.

COVID-19, excess all-cause mortality in US, 18 comparison countries
COVID-19 deaths and excess all-cause mortality in the U.S. are compared with 18 countries with diverse COVID-19 responses in this study.

New analysis shows hydroxychloroquine does not lower mortality in COVID-19 patients, and is associated with increased mortality when combined with the antibiotic azithromycin
A new meta-analysis of published studies into the drug hydroxychloroquine shows that it does not lower mortality in COVID-19 patients, and using it combined with the antibiotic azithromycin is associated with a 27% increased mortality.

Hydroxychloroquine reduces in-hospital COVID-19 mortality
An Italian observational study contributes to the ongoing debate regarding the use of hydroxychloroquine in the current pandemic.

What's the best way to estimate and track COVID-19 mortality?
When used correctly, the symptomatic case fatality ratio (sCFR) and the infection fatality ratio (IFR) are better measures by which to monitor COVID-19 epidemics than the commonly reported case fatality ratio (CFR), according to a new study published this week in PLOS Medicine by Anthony Hauser of the University of Bern, Switzerland, and colleagues.

COVID-19: Bacteriophage could decrease mortality
Bacteriophage can reduce bacterial growth in the lungs, limiting fluid build-up.

COPD and smoking associated with higher COVID-19 mortality
Current smokers and people with chronic obstructive pulmonary disease (COPD) have an increased risk of severe complications and higher mortality with COVID-19 infection, according to a new study published May 11, 2020 in the open-access journal PLOS ONE by Jaber Alqahtani of University College London, UK, and colleagues.

Highest mortality risks for poor and unemployed
Large dataset shows that income, work status and education have a clear influence on mortality in Germany.

Addressing causes of mortality in Zambia
Despite the fact that people in sub-Saharan Africa are now living longer than they did two decades ago, their average life expectancy remains below that of the rest of the world population.

Read More: Mortality News and Mortality Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.